ECOG Performance Status 1

Known as: ECOG 1 
Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office… (More)

Topic mentions per year

Topic mentions per year

1994-2018
051019942018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
PURPOSE BRAF-mutant metastatic colorectal cancer (mCRC) forms an aggressive subset of colorectal cancer with minimal response to… (More)
  • table 1
  • table 2
Is this relevant?
2014
2014
PURPOSE Providing survival estimates is important for decision making in oncology care. The purpose of this study was to provide… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2011
2011
4501 Background: "Intracrine" androgen signaling is linked to castrate-resistant prostate cancer (CRPC) and a "credentialed… (More)
Is this relevant?
2011
2011
In unresectable intrahepatic cholangiocarcinoma (ICC), systemic chemotherapy often is viewed as the only option, although… (More)
  • table 3
  • table 2
  • figure 2
  • table 4
  • figure 3
Is this relevant?
2011
2011
UNLABELLED New therapeutic approaches are being developed based on the findings that several genetic abnormalities underlying… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 3
Is this relevant?
2006
2006
13005 Background: AMG 706 is an investigational, oral, multi-kinase inhibitor with both antiangiogenic and direct antitumor… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE (1) Identify clinical factors that can be used to predict survival in chemotherapy-naive patients with advanced non-small… (More)
Is this relevant?
2004
2004
3593 Background: Although surgical resection remains the treatment of choice for liver metastases from colorectal cancer, only a… (More)
Is this relevant?
2004
2004
2001 Background: Aberrant VEGFR expression in breast tumor cells and EGFR expression in endothelial cells may contribute to tumor… (More)
Is this relevant?
1995
1995
135 patients with locally advanced or metastatic colorectal cancer were entered into a phase III trial evaluating the efficacy of… (More)
Is this relevant?